Market News

Evanson Asset Management Has Raised Stake in Exxon Mobil (XOM); Duquesne Family Office Has Raised Its Position in Nektar Therapeutics (NKTR) as Share Value Rose

Nektar Therapeutics (NASDAQ:NKTR) Logo

Evanson Asset Management Llc increased its stake in Exxon Mobil Corp (XOM) by 13.11% based on its latest 2017Q4 regulatory filing with the SEC. Evanson Asset Management Llc bought 5,478 shares as the company’s stock declined 12.23% with the market. The institutional investor held 47,261 shares of the integrated oil company at the end of 2017Q4, valued at $3.95 million, up from 41,783 at the end of the previous reported quarter. Evanson Asset Management Llc who had been investing in Exxon Mobil Corp for a number of months, seems to be bullish on the $334.33 billion market cap company. The stock decreased 0.09% or $0.07 during the last trading session, reaching $78.93. About 4.38M shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 9.29% since April 23, 2017 and is downtrending. It has underperformed by 20.84% the S&P500.

Stanley Druckenmiller increased its stake in Nektar Therapeutics (NKTR) by 57.28% based on its latest 2017Q4 regulatory filing with the SEC. Duquesne Family Office Llc bought 667,900 shares as the company’s stock rose 80.22% while stock markets declined. The hedge fund run by Stanley Druckenmiller held 1.83 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $109.53M, up from 1.17M at the end of the previous reported quarter. Duquesne Family Office Llc who had been investing in Nektar Therapeutics for a number of months, seems to be bullish on the $13.37 billion market cap company. The stock decreased 3.63% or $3.13 during the last trading session, reaching $83.08. About 1.22M shares traded. Nektar Therapeutics (NASDAQ:NKTR) has risen 347.01% since April 23, 2017 and is uptrending. It has outperformed by 335.46% the S&P500.

Duquesne Family Office Llc, which manages about $1.98B US Long portfolio, decreased its stake in Vale S A (NYSE:VALE) by 812,200 shares to 1.67M shares, valued at $20.38 million in 2017Q4, according to the filing.

Among 11 analysts covering Nektar Therapeutics (NASDAQ:NKTR), 11 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Nektar Therapeutics had 27 analyst reports since August 6, 2015 according to SRatingsIntel. Aegis Capital initiated the shares of NKTR in report on Tuesday, November 8 with “Buy” rating. The stock has “Overweight” rating by PiperJaffray on Friday, April 13. The company was initiated on Thursday, November 9 by Canaccord Genuity. The stock of Nektar Therapeutics (NASDAQ:NKTR) earned “Buy” rating by Cowen & Co on Monday, April 9. Jefferies maintained the shares of NKTR in report on Wednesday, November 8 with “Buy” rating. As per Friday, April 6, the company rating was maintained by Mizuho. The stock has “Buy” rating by J.P. Morgan on Tuesday, July 18. The stock has “Buy” rating by Canaccord Genuity on Wednesday, January 10. On Wednesday, August 16 the stock rating was maintained by Jefferies with “Buy”. Roth Capital maintained it with “Buy” rating and $45.0 target in Monday, November 13 report.

Since December 13, 2017, it had 0 insider purchases, and 18 sales for $68.39 million activity. Hora Maninder also sold $53,046 worth of Nektar Therapeutics (NASDAQ:NKTR) shares. Another trade for 160,000 shares valued at $14.89M was made by Doberstein Stephen K on Friday, April 6. Lingnau Lutz had sold 30,000 shares worth $3.05M. Shares for $2.77 million were sold by GREER R SCOTT on Friday, April 6. $1.76 million worth of Nektar Therapeutics (NASDAQ:NKTR) was sold by KUEBLER CHRISTOPHER A. The insider ROBIN HOWARD W sold 83,333 shares worth $6.32 million.

Investors sentiment decreased to 1.19 in 2017 Q4. Its down 0.21, from 1.4 in 2017Q3. It worsened, as 18 investors sold NKTR shares while 82 reduced holdings. 65 funds opened positions while 54 raised stakes. 150.36 million shares or 1.08% more from 148.76 million shares in 2017Q3 were reported. Moreover, Schroder Investment Mngmt has 0% invested in Nektar Therapeutics (NASDAQ:NKTR). Arizona State Retirement System reported 0.15% in Nektar Therapeutics (NASDAQ:NKTR). 233,964 are held by California State Teachers Retirement Sys. Citadel Limited Liability has 0% invested in Nektar Therapeutics (NASDAQ:NKTR). Camber Capital Management Ltd Liability Corp stated it has 9.79% in Nektar Therapeutics (NASDAQ:NKTR). Primecap Mngmt Ca reported 1.02% in Nektar Therapeutics (NASDAQ:NKTR). State Common Retirement Fund reported 169,785 shares. Walleye Trading Limited Com invested in 20,187 shares. Piedmont Inv Advsrs Limited Co has 32,367 shares. Jefferies Group Llc stated it has 20,000 shares. Aperio Group Inc Limited Liability Corp has 0.02% invested in Nektar Therapeutics (NASDAQ:NKTR). Susquehanna Gru Limited Liability Partnership owns 785,618 shares for 0.02% of their portfolio. Ls Inv Advsr Limited Liability Company invested 0.02% in Nektar Therapeutics (NASDAQ:NKTR). Brinker Cap invested in 0.05% or 20,557 shares. First Mercantile Trust, a Tennessee-based fund reported 4,984 shares.

Since December 11, 2017, it had 0 insider purchases, and 4 insider sales for $3.42 million activity. On Friday, December 15 Wascom Dennis G sold $200,293 worth of Exxon Mobil Corporation (NYSE:XOM) or 2,412 shares. Corson Bradley W sold $1.62M worth of Exxon Mobil Corporation (NYSE:XOM) on Monday, December 11. 12,000 shares were sold by Chapman Neil A, worth $996,628 on Thursday, December 14.

Investors sentiment decreased to 0.84 in Q4 2017. Its down 0.01, from 0.85 in 2017Q3. It worsened, as 48 investors sold XOM shares while 819 reduced holdings. 123 funds opened positions while 603 raised stakes. 2.17 billion shares or 1.92% more from 2.13 billion shares in 2017Q3 were reported. Financial Consulate invested 0.94% of its portfolio in Exxon Mobil Corporation (NYSE:XOM). 51,238 were reported by Ftb Advsrs Inc. 44,081 were accumulated by Jones Financial Lllp. Alpine Mgmt Lc holds 17,468 shares or 0.33% of its portfolio. State Teachers Retirement stated it has 7.20 million shares. California-based Cohen has invested 0.67% in Exxon Mobil Corporation (NYSE:XOM). Thomas J Herzfeld Inc reported 363 shares. Tsp Capital Mgmt Group Limited Liability Company has 18,231 shares. Coastline Tru Comm holds 0.5% or 40,028 shares. Iowa Bank owns 57,378 shares or 2.16% of their US portfolio. Two Sigma Secs Limited Liability reported 23,313 shares. Montgomery Invest Mgmt Inc invested 0.77% of its portfolio in Exxon Mobil Corporation (NYSE:XOM). 36,489 were accumulated by Van Strum & Towne. Creative Planning accumulated 1.08M shares. Cadence Fincl Bank Na, Texas-based fund reported 321,614 shares.

Exxon Mobil Corporation (NYSE:XOM) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *